Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-17
2006-10-17
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S277000, C514S318000, C514S332000, C514S544000, C544S124000, C546S194000, C552S293000, C552S307000
Reexamination Certificate
active
07122543
ABSTRACT:
A substituted benzoic acid derivative which is represented by the following formula (I) and has an NF-κB inhibiting action (in the formula, R3, R4and R5each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an alkoxy group having 1 to 6 carbon(s); R9and R10each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an acyl group having 2 to 11 carbons); R2represents an optionally-substituted aromatic hydrocarbon group or an optionally-substituted heterocyclic group; and X represents a carboxyl group which may be esterified or amidated)
REFERENCES:
patent: 6156516 (2000-12-01), Nunokawa
patent: 7-291859 (1995-11-01), None
patent: 11-266872 (1998-03-01), None
patent: 99/48491 (1999-09-01), None
patent: 01/21206 (2001-03-01), None
patent: 02/76918 (2002-10-01), None
Nunokawa Yoichi
Suzuki Kenji
Badio Barbara P.
Daiichi Suntory Pharma Co., Ltd.
Drinker Biddle & Reath LLP
LandOfFree
Substituted benzoic acid derivatives having NF-κB... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoic acid derivatives having NF-κB..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoic acid derivatives having NF-κB... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3715763